Table 6.
AD biomarker | Variables | Type of stenosis | B | SE | p |
---|---|---|---|---|---|
Neurodegeneration biomarker | HVa | Any intracranial stenosis | − 84.119 | 158.679 | 0.597 |
Number of stenotic intracranial arteries ≥ 2 | − 428.816 | 184.921 | 0.021*† |
Covariates for confirmatory multivariable analyses include age, sex, APOE4 carrier status, and clinical diagnosis (mild cognitive impairment or AD dementia). Units for AD biomarker variables are as follows: SUVR for global Aβ, mm for AD-CT, and mm3 for HVa. When Bonferroni-corrected p value was applied for confirmatory multivariable analyses regarding neurodegeneration biomarkers, the association between presence of number of stenotic intracranial arteries ≥ 2 and lower HVa in the CI group remained significant
AD Alzheimer’s disease, CI cognitively impaired, SE standard error, SUVR standardized uptake value ratio, HVa hippocampal volume adjusted for intracranial volume
aNo significant findings in the exploratory univariable analyses step regarding Aβ biomarker and AD-CT
*p < 0.05 (before Bonferroni correction)
†p < 0.025 (Bonferroni-corrected p < 0.05/2 = 0.025 was used as a statistical threshold)